Asthalin Inhaler (Albuterol 100 mcg) Metered-Dose Inhaler

Asthalin Inhaler is a metered-dose inhaler that delivers albuterol, a fast-acting bronchodilator, in 100 mcg doses per actuation for oral inhalation. People living with asthma, chronic bronchitis, or exercise-induced bronchospasm commonly rely on an inhaler like this one to open narrowed airways within minutes. We stock Asthalin Inhaler in package sizes ranging from a single inhaler up to ten, so a household can match its order to how often the medicine is used. The rest of this article walks through how albuterol works, how it is typically dosed, what to watch for, and how it compares with other bronchodilator options.

What Asthalin Inhaler Is

Asthalin Inhaler contains albuterol (also called salbutamol outside the United States), a short-acting beta2-adrenergic agonist. Each actuation of the metered-dose inhaler releases 100 mcg of albuterol, and the canister is designed for oral inhalation directly into the lungs rather than swallowing or nasal use. This puts Asthalin Inhaler in the same pharmacological family as other albuterol rescue inhalers, though brand, canister design, and formulation details can differ between manufacturers. The active ingredient, dosage form, route, and strength stay the same across every package size we offer, from one inhaler through ten inhalers.

Asthma, Bronchospasm, and Why a Rescue Inhaler Matters

Asthma and related airway conditions involve episodes of bronchospasm, in which the smooth muscle around the airways tightens and airway inflammation contributes to narrowing the passage for air. This produces the wheezing, chest tightness, coughing, and shortness of breath that people describe during an asthma flare or an attack triggered by exercise, cold air, allergens, or respiratory infection. A short-acting bronchodilator such as albuterol relaxes airway muscle quickly, independent of what triggered the spasm. People who explore our inhaler listing alongside other options in our asthma treatments section may be comparing a rapid bronchodilator like this one with longer-acting maintenance therapies that are used differently.

How Albuterol Works in the Airways

Albuterol acts on beta2-adrenergic receptors found on the smooth muscle that lines the bronchi and bronchioles. Stimulating these receptors raises intracellular cyclic AMP, which relaxes the surrounding muscle and widens the airway. Because albuterol is relatively selective for beta2 receptors rather than the beta1 receptors concentrated in the heart, it produces bronchodilation with less direct cardiac stimulation than nonselective adrenergic agonists. However, some cardiac effects and systemic absorption can still occur, particularly with higher or repeated inhaled doses. Albuterol may also reduce the release of some mediators from airway mast cells, but this is secondary to its direct bronchodilator action and does not make it an anti-inflammatory controller medicine.

Evidence Behind Albuterol's Use

Albuterol has been used as a rapid-acting bronchodilator for decades. Clinical trials and extensive clinical experience show measurable improvement in airflow, including forced expiratory volume in one second (FEV1), within minutes of an inhaled dose. This established record explains its continuing role in quickly reversing bronchospasm and preventing exercise-induced bronchospasm.

Its role should still be understood in the context of modern asthma care. Current guidelines emphasize that repeated symptom relief with a short-acting beta2 agonist does not treat the airway inflammation underlying asthma, and many patients are advised to use an inhaled corticosteroid-containing reliever or controller strategy. The appropriate plan depends on age, asthma severity, available products, and the prescriber's instructions.

Formulation and What Each Actuation Delivers

Asthalin Inhaler is supplied as a pressurized metered-dose inhaler. Every press of the canister provides a metered 100 mcg actuation of albuterol for inhalation through the mouthpiece. Although the device meters each actuation, inhalation technique strongly affects how much medicine reaches the lower airways instead of remaining in the mouth or throat.

A typical technique involves shaking the inhaler if directed by its instructions, breathing out fully, sealing the lips around the mouthpiece, beginning a slow and deep inhalation while pressing the canister, and then holding the breath briefly if able. Product-specific directions should be followed for priming, cleaning, and the interval between actuations. A clinician or pharmacist can demonstrate technique, and a compatible spacer or valved holding chamber may help people who have difficulty coordinating actuation with inhalation.

Established Uses

Albuterol metered-dose inhalers are used to relieve bronchospasm associated with asthma and other reversible obstructive airway conditions and to prevent exercise-induced bronchospasm when taken shortly before physical activity. Albuterol is used as a rescue medicine for sudden symptoms and, in some regimens, as pretreatment before a known trigger such as exertion in cold air. It is not designed to provide the anti-inflammatory control needed for persistent asthma; that role belongs to inhaled corticosteroids or appropriate combination inhalers.

Sudden breathing difficulty that does not improve after the prescribed rescue treatment requires urgent medical attention. A canister that is empty, blocked, used incorrectly, or past its labeled number of actuations may fail to provide the expected dose, so patients should monitor the dose counter when the device has one and replace the inhaler according to its instructions.

Strengths, Package Options, and General Dosing Principles

We offer Asthalin Inhaler in a single strength, 100 mcg per actuation, with package quantities from one inhaler up to ten inhalers. General albuterol inhaler dosing for adults and children age 4 years and older often involves one or two inhalations for bronchospasm, repeated according to the product labeling and the prescriber's directions. For prevention of exercise-induced bronchospasm, the prescribed inhalations are usually taken shortly before activity. These are general patterns rather than an individualized regimen; the exact number of inhalations, timing, interval between doses, and maximum daily use should come from the patient's prescription and treatment plan.

Needing albuterol more often than usual, waking at night with symptoms, replacing canisters unusually quickly, or obtaining less relief from the usual dose can indicate worsening airway disease. These changes call for medical reassessment rather than independent dose escalation. Children should use the inhaler with age-appropriate supervision and technique support, and safety and effectiveness are not established for every albuterol inhaler in children younger than 4 years.

Onset, Duration, and Elimination and Half-Life

Inhaled albuterol generally begins relaxing airway muscle within about 5 minutes, reaches peak bronchodilator effect around 30 to 60 minutes after inhalation, and often remains effective for 4 to 6 hours. The portion that reaches systemic circulation is metabolized in the liver and other tissues, including through sulfate conjugation, and albuterol and its metabolites are eliminated mainly in urine. Reported terminal half-life values are commonly around 3.5 to 5 hours, although individual pharmacokinetics can vary.

These milestones explain why relief can start quickly but is not permanent. Repeated overuse within a short period can increase systemic exposure and adverse effects without adequately treating worsening airway inflammation or a severe asthma attack.

Important Safety Information

Albuterol is generally well tolerated at recommended doses, but tremor, nervousness, and a fast or pounding heartbeat can occur because of its beta-adrenergic effects. Anyone whose rescue inhaler use is increasing, or who needs it more often than the pattern described in the treatment plan, should regard that as a reason for reassessment rather than simply using progressively more albuterol.

Use requires additional caution in people with cardiovascular disease, heart rhythm disorders, high blood pressure, hyperthyroidism, diabetes, seizure disorders, or a tendency toward low potassium. Albuterol can occasionally produce clinically significant changes in heart rate or blood pressure. It can also lower serum potassium transiently, especially at high doses, and may raise blood glucose.

Paradoxical bronchospasm is a rare but serious reaction in which wheezing becomes worse immediately after inhalation. If this happens, stop using that inhaler and obtain urgent medical care. Sudden loss of response to a previously effective inhaler can also indicate deteriorating asthma and should not be managed by repeated unsupervised dosing.

Prescription Status and How Ordering Works With Us

In the United States, albuterol is authorized for human medicinal use, and the metered-dose inhaler dosage form is classified as a prescription medicine. That classification is separate from the product-specific documentation our ordering process may require. Because the current requirement for accepting an Asthalin Inhaler order is not specified here, customers should confirm the applicable steps during checkout or with our support team rather than assume that no prescription is needed.

Our pharmacist-supported team is available 24/7 by phone, email, and online chat to explain our current ordering process. We have operated as an online pharmacy since 2008, and our team can also answer general questions about inhaler technique, storage, available quantities, or how the package options are presented on our site.

Contraindications

Albuterol is contraindicated in anyone with a known hypersensitivity to albuterol or to any component of the specific inhaler formulation. A general or unspecified allergy history is not itself a reason to avoid albuterol, but the product's ingredient information should be checked if a person has previously reacted to an inhaler.

Cardiovascular disease, diabetes, hyperthyroidism, seizure disorders, and low potassium are generally precautions rather than absolute contraindications. A clinician weighs the expected bronchodilator benefit against the risk and determines whether additional monitoring or a different treatment is appropriate.

Interactions

Other sympathomimetic medicines, including some decongestants and bronchodilators, can add to albuterol's effects on heart rate, tremor, and blood pressure. Using multiple rapid bronchodilators without clinical direction may increase adverse effects without improving control of the underlying condition.

Beta-blockers can blunt albuterol's bronchodilating action and may provoke bronchospasm in susceptible people. When a beta-blocker is medically necessary, the prescriber considers the respiratory risk, the reason for treatment, and whether a relatively beta1-selective medicine is suitable. Patients should not stop a prescribed beta-blocker on their own.

Non-potassium-sparing diuretics can add to albuterol-associated reductions in potassium, particularly when high beta-agonist doses are used. Monoamine oxidase inhibitors and tricyclic antidepressants may intensify cardiovascular effects; caution is commonly advised during concurrent use and for a period after those medicines are discontinued. Digoxin concentrations may also change in some patients receiving albuterol, so clinicians may monitor more closely when the combination is clinically important.

Side Effects and When to Take Action

The most common effects reported with albuterol inhalers include tremor, headache, nervousness, throat irritation, cough, and a fast heartbeat. Many are mild and diminish as the dose wears off. Cough, dry mouth, or throat discomfort immediately after inhalation can reflect local irritation, the formulation, or inhaler technique; persistent symptoms should be discussed with a clinician or pharmacist.

• Ordinary, usually short-lived effects: mild tremor, restlessness, headache, throat irritation, cough, and a temporary increase in heart rate.
• Effects that call for prompt medical attention: chest pain, a rapid or irregular heartbeat that does not settle, significant dizziness or fainting, severe muscle weakness, or wheezing that worsens instead of improving after a dose.
• Signs of a serious allergic reaction requiring emergency care: swelling of the face, lips, tongue, or throat, sudden difficulty breathing, or widespread hives.

People with diabetes should be aware that beta-agonists can cause a transient rise in blood glucose, so additional monitoring may be appropriate during periods of frequent use. Anyone who is pregnant should discuss treatment with a clinician. Maintaining asthma control during pregnancy is important, but available human data do not establish every potential risk, so treatment is individualized.

There are limited data on albuterol in human milk. Systemic exposure after inhalation is low, but a clinician can weigh the mother's need for treatment against any potential effect on the breastfed infant. Tremor, dizziness, nervousness, or palpitations may temporarily affect driving or other tasks requiring concentration, especially until the individual response is known.

Overdose and Toxicity

Taking substantially more albuterol than directed, whether through repeated extra actuations or unusually frequent use, can intensify its systemic effects rather than provide proportionally greater airway relief. Signs of overexposure can include a markedly fast or irregular heartbeat, chest pain, pronounced tremor, severe headache, nausea, hyperglycemia, low blood potassium, metabolic acidosis, and seizures in severe cases. Low potassium can itself increase the risk of abnormal heart rhythms.

Anyone who may have used far more than the intended amount, or who develops severe chest pain, fainting, seizures, or an irregular heartbeat, should seek emergency medical care or contact Poison Control in the United States at 1-800-222-1222. Overuse of a rescue inhaler is also a warning sign that the underlying airway condition may not be adequately controlled and needs medical reassessment.

Storage

Store Asthalin Inhaler below 86°F and protect it from direct sunlight and heat. Because the canister is pressurized, it should not be punctured, burned, or placed in a fire, even when it appears empty. Avoid leaving it in a hot car or near a heater. Keep the inhaler out of the reach of children and follow the product instructions for mouthpiece cleaning and disposal.

The inhaler should remain readily accessible to the person for whom it was prescribed, but it should not be shared. Check the mouthpiece for blockage and monitor the labeled actuation limit or dose counter, if present. A canister may continue to spray propellant after its labeled medication doses have been used, so shaking or test-spraying it is not a reliable way to determine how much medicine remains.

Benefits and Trade-Offs

The clearest benefit of Asthalin Inhaler is speed: inhaled albuterol reaches airway smooth muscle directly, so bronchodilation typically begins within minutes. Its relative beta2 selectivity generally produces less direct cardiac stimulation than nonselective adrenergic agonists, although tremor, palpitations, and a faster heartbeat remain possible. A metered-dose inhaler is portable and can deliver treatment without a nebulizer or external power source.

The trade-off is that albuterol treats bronchospasm but not the persistent airway inflammation that drives asthma. It is not a substitute for an inhaled corticosteroid or other controller when one is prescribed. Effective use also depends on technique, device condition, and dose availability. Frequent reliance, declining response, or symptoms that return quickly are reasons to revisit the overall treatment plan rather than increase use independently.

Asthalin Inhaler, Ventolin Tablets, and Other Airway Medicines

Albuterol is the generic active ingredient used in multiple inhaled products, and our albuterol page provides a broader view of medicines sharing that ingredient. Asthalin Inhaler is a 100 mcg-per-actuation metered-dose inhaler. By contrast, our Ventolin product contains albuterol in oral tablets rather than a metered-dose inhaler. The active ingredient is related, but the dosage form, route, strength units, onset, and dosing instructions differ, so the tablet and inhaler should not be treated as interchangeable.

Other albuterol inhalers have been marketed under names such as ProAir, Proventil, and Airomir. Device resistance, priming instructions, dose counters, propellants, labeled ages, and the amount delivered per actuation can vary, so patients should not assume that every branded device is used identically. Levalbuterol, marketed as Xopenex, is the R-enantiomer of albuterol and is a related short-acting bronchodilator. Some clinicians select it for individual patients, but it is not uniformly superior and can still cause tremor, palpitations, and other beta-agonist effects.

For ongoing airway inflammation rather than immediate symptom relief, maintenance inhalers serve a different purpose. For example, Advair Diskus combines an inhaled corticosteroid with a long-acting bronchodilator and is used on a scheduled basis; it is not a substitute for a rapid-acting medicine during sudden bronchospasm. Understanding the distinction between rapid bronchodilation and ongoing anti-inflammatory control helps explain why a prescriber may recommend Asthalin Inhaler alongside, rather than instead of, a separate maintenance treatment.